Matches in Wikidata for { <http://www.wikidata.org/entity/Q82851216> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- Q82851216 description "2010 թվականի փետրվարի 11-ին հրատարակված գիտական հոդված" @default.
- Q82851216 description "article scientifique publié en 2010" @default.
- Q82851216 description "artículu científicu espublizáu en febreru de 2010" @default.
- Q82851216 description "scientific article published on 11 February 2010" @default.
- Q82851216 description "wetenschappelijk artikel" @default.
- Q82851216 description "наукова стаття, опублікована в лютому 2010" @default.
- Q82851216 name "A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cance" @default.
- Q82851216 name "A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cance" @default.
- Q82851216 type Item @default.
- Q82851216 label "A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cance" @default.
- Q82851216 label "A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cance" @default.
- Q82851216 prefLabel "A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cance" @default.
- Q82851216 prefLabel "A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cance" @default.
- Q82851216 P1433 Q82851216-A721FA05-DD56-444D-9884-93975B8E36A9 @default.
- Q82851216 P1476 Q82851216-BB79B2AD-45ED-4554-8BC0-3E8FD3EC97C1 @default.
- Q82851216 P2093 Q82851216-05141C64-73AC-43AE-BD30-A0320EBF1CA6 @default.
- Q82851216 P2093 Q82851216-3289C1E7-ED86-4AEB-B3C5-1C45A2701659 @default.
- Q82851216 P2093 Q82851216-53C818C4-3A25-449F-8923-CF06425C5FEB @default.
- Q82851216 P2093 Q82851216-5B80E4AE-EC5B-42D3-9DDF-AF91B63F644B @default.
- Q82851216 P2093 Q82851216-713E13B6-460D-4BBE-93AD-74063EDDAC3C @default.
- Q82851216 P2093 Q82851216-D5CF67C6-9725-4CF9-AC79-D064090F5012 @default.
- Q82851216 P2860 Q82851216-01A19904-6F06-49FF-835C-D596A08A6455 @default.
- Q82851216 P2860 Q82851216-05CC3410-C746-4E61-A695-3C76EEEBBA71 @default.
- Q82851216 P2860 Q82851216-0C9A4949-AB88-48BC-8866-854438ECA02E @default.
- Q82851216 P2860 Q82851216-0D6E3865-D117-438A-A1EF-5B2AADB06F2E @default.
- Q82851216 P2860 Q82851216-34BCF4A1-181E-4518-85C8-E1A15B8228C4 @default.
- Q82851216 P2860 Q82851216-35B18DF7-9789-4543-98CB-D16F62A36DF5 @default.
- Q82851216 P2860 Q82851216-400EFEE5-8C60-463B-91B1-607D8F03B554 @default.
- Q82851216 P2860 Q82851216-4D67E3E7-19FC-4BE1-A299-F47BD96C71C6 @default.
- Q82851216 P2860 Q82851216-5B5C30CD-0A64-4EFE-91B6-1F6B55F812B6 @default.
- Q82851216 P2860 Q82851216-63E69224-E5D9-42DD-AA8B-E2B0956A5248 @default.
- Q82851216 P2860 Q82851216-7D86029B-2B43-4AA0-9982-021FDABAE401 @default.
- Q82851216 P2860 Q82851216-AD92BB9E-8B6D-4678-9F40-00E9CED86573 @default.
- Q82851216 P2860 Q82851216-D5CD2265-D2B7-4C3C-9E97-8BAD69A99F3B @default.
- Q82851216 P2860 Q82851216-DB2C835F-5AD7-4F58-8D8C-40628EFFD87B @default.
- Q82851216 P2860 Q82851216-E10A4705-F070-4179-A5F4-C64A785B10BA @default.
- Q82851216 P2860 Q82851216-E45D4786-F408-4AEF-9A70-F3C91FDAF6A6 @default.
- Q82851216 P2860 Q82851216-E4953ABB-5D5A-4E30-BE95-174DDC8D46D6 @default.
- Q82851216 P2860 Q82851216-E5B0606C-0656-471E-9484-3641D2508B4A @default.
- Q82851216 P2860 Q82851216-E8B4F5E8-32AD-4470-87CD-421AB7E65E05 @default.
- Q82851216 P2888 Q82851216-6A1FDF33-4D49-42F4-B4A6-3B0D1807B056 @default.
- Q82851216 P304 Q82851216-3E53449D-EF90-4DCF-B716-9476592BE679 @default.
- Q82851216 P31 Q82851216-21901907-4BB2-4974-AD0C-0AA9CC82772B @default.
- Q82851216 P356 Q82851216-EDA10401-C699-4B01-BBCB-3487C5A30952 @default.
- Q82851216 P433 Q82851216-7DB59480-5296-4936-B70D-7798903006FE @default.
- Q82851216 P478 Q82851216-BA5DE2FA-380C-4D54-8020-B55D0A3461D5 @default.
- Q82851216 P577 Q82851216-4C0B6185-DAB2-4A17-90E2-6037CEA872A9 @default.
- Q82851216 P6179 Q82851216-E4ACE284-95B6-4753-8F75-739E53E73752 @default.
- Q82851216 P698 Q82851216-F3B12EEB-BB47-4304-8E22-F6498D6CAAAF @default.
- Q82851216 P921 Q82851216-50B8AD38-5A72-48F4-9E10-71C91CC5A6A3 @default.
- Q82851216 P921 Q82851216-F7238423-7BE0-4780-887F-4DB23F93C376 @default.
- Q82851216 P356 S10637-010-9388-4 @default.
- Q82851216 P698 20145975 @default.
- Q82851216 P1433 Q2312231 @default.
- Q82851216 P1476 "A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer" @default.
- Q82851216 P2093 "Brenda Foster" @default.
- Q82851216 P2093 "Franklin M Chu" @default.
- Q82851216 P2093 "Joel Picus" @default.
- Q82851216 P2093 "Paula M Fracasso" @default.
- Q82851216 P2093 "Robert Dreicer" @default.
- Q82851216 P2093 "Zhihui Lang" @default.
- Q82851216 P2860 Q24682923 @default.
- Q82851216 P2860 Q27860585 @default.
- Q82851216 P2860 Q29616218 @default.
- Q82851216 P2860 Q29619679 @default.
- Q82851216 P2860 Q29619681 @default.
- Q82851216 P2860 Q30306982 @default.
- Q82851216 P2860 Q34558153 @default.
- Q82851216 P2860 Q34600581 @default.
- Q82851216 P2860 Q35764323 @default.
- Q82851216 P2860 Q36309725 @default.
- Q82851216 P2860 Q37242288 @default.
- Q82851216 P2860 Q40394237 @default.
- Q82851216 P2860 Q40453891 @default.
- Q82851216 P2860 Q40639692 @default.
- Q82851216 P2860 Q40961756 @default.
- Q82851216 P2860 Q63965940 @default.
- Q82851216 P2860 Q71644976 @default.
- Q82851216 P2860 Q73568327 @default.
- Q82851216 P2860 Q73605064 @default.
- Q82851216 P2888 s10637-010-9388-4 @default.
- Q82851216 P304 "674-679" @default.
- Q82851216 P31 Q13442814 @default.
- Q82851216 P356 "10.1007/S10637-010-9388-4" @default.
- Q82851216 P433 "4" @default.
- Q82851216 P478 "29" @default.
- Q82851216 P577 "2010-02-11T00:00:00Z" @default.
- Q82851216 P6179 "1043459162" @default.
- Q82851216 P698 "20145975" @default.
- Q82851216 P921 Q420436 @default.
- Q82851216 P921 Q422248 @default.